removab
neovii biotech gmbh - catumaxomab - ascites; cancer - other antineoplastic agents - removab is indicated for the intraperitoneal treatment of malignant ascites in patients with epcam-positive carcinomas where standard therapy is not available or no longer feasible.,
grafalon 20 mg/ml concentrate for solution for infusion
neovii biotech gmbh - anti-human t-lymphocyte immunoglobulin from rabbits - concentrate for solution for infusion - 20 milligram(s)/millilitre - selective immunosuppressants; antithymocyte immunoglobulin (rabbit)
grafalon 20 mgml
fresenius kabi (singapore) pte ltd - rabbit anti-human t-lymphocyte immunoglobulin - infusion, solution concentrate - 20 mg/ml - rabbit anti-human t-lymphocyte immunoglobulin 20 mg/ml
removab 10micrograms0.1ml concentrate for solution for infusion pre-filled syringes
neovii biotech gmbh - catumaxomab - solution for infusion - 100microgram/1ml
removab 50micrograms0.5ml concentrate for solution for infusion pre-filled syringes
neovii biotech gmbh - catumaxomab - solution for infusion - 100microgram/1ml
grafalon 20 mg/ml inf. sol. (conc.) i.v. vial
neovii biotech gmbh - immunoglobulinum caniculi anti-t-lymphocytum humanum 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - human anti-t-lymphocyte immunoglobulin (origin rabbits) 20 mg/ml - antithymocyte immunoglobulin (rabbit)
grafalon
cure medical & technical supply - rabbit immunoglobulin - concentrate for solution for infusion - rabbit immunoglobulin 20 mg/ml - rabies immunoglobulin - - prophylaxis and therapy of rejection crises in organ and tissue transplantations.- prevention of graft-versus-host disease (gvhd) in adults after allogeneic stem cell transplantation (sct) grafalon is indicated for prevention of graft-versus-host disease (gvhd) in adults with haematological malignancies following stem cell transplantation from matched unrelated donors in combination with standard cyclosporin a/methotrexate prophylaxis
grafalon 20mg/ml sterile concentrate infusion
gulf drug llc germany - 5ml vial x 10 - infusion - 20mg/ml - malignant disease,immunosuppresion-immune response
grafalon 20mg/ml concentrate for solution for infusion
neovis totalmilti (ophthalmic lubricant emulsion) 0.18%
شركة مستودع ادوية الموزع الطبي - شركة مستودع ادوية الموزع الطبي - sodium hyalurnate 0.18 % - 0.18%